找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Disease Recurrence After Liver Transplantation; Natural History, Tre Paul J. Thuluvath Book 2016 Springer Science+Business Media New York 2

[復(fù)制鏈接]
樓主: otitis-externa
11#
發(fā)表于 2025-3-23 11:14:35 | 只看該作者
12#
發(fā)表于 2025-3-23 14:28:59 | 只看該作者
13#
發(fā)表于 2025-3-23 19:12:16 | 只看該作者
14#
發(fā)表于 2025-3-23 22:22:50 | 只看該作者
15#
發(fā)表于 2025-3-24 03:28:08 | 只看該作者
Treatment of Recurrent Hepatitis C,e the natural history of recurrent hepatitis. Preliminary studies indicate that approximately 90 % of people with recurrent HCV could be cured with a combination of direct acting antiviral drugs with minimal side effects.
16#
發(fā)表于 2025-3-24 08:52:59 | 只看該作者
17#
發(fā)表于 2025-3-24 12:01:43 | 只看該作者
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation,s are limited for recurrent PSC. For these important entities affecting PSC patients after liver transplantation, we review the current published data on epidemiology, diagnostic criteria, risk factors, graft and patient survival, and treatment of recurrent PSC.
18#
發(fā)表于 2025-3-24 17:21:01 | 只看該作者
19#
發(fā)表于 2025-3-24 19:51:58 | 只看該作者
Recurrence of HCC When Transplanted Outside Milan Criteria,r LT. The main disadvantage of this set of criteria is that it is relatively restrictive. Several attempts have been made to expand these criteria to include tumors of greater number and size. The model for end-stage liver disease (MELD) prioritization system has utilized the Milan criteria since ad
20#
發(fā)表于 2025-3-24 23:09:01 | 只看該作者
Role of Neoadjuvant and Adjuvant Treatment in HCC Recurrence After Liver Transplantation, the Milan criteria have been shown to be 8–15 % and higher in those patients beyond the Milan criteria. The value of adjuvant therapy using systemic cytotoxic chemotherapy after LT has been disappointing. Sorafenib has been used for treatment in recurrent HCC after LT, and the data of safety and ef
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 22:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
绵阳市| 安徽省| 保德县| 灌南县| 墨玉县| 台东市| 修水县| 天全县| 临洮县| 青田县| 年辖:市辖区| 堆龙德庆县| 华阴市| 株洲县| 黎川县| 招远市| 伊宁县| 璧山县| 巴彦淖尔市| 南川市| 吉木萨尔县| 庆安县| 大港区| 新蔡县| 军事| 兴宁市| 北票市| 尼勒克县| 屯门区| 临汾市| 肇州县| 凌源市| 上高县| 永济市| 兴国县| 贵州省| 会昌县| 宝山区| 长沙县| 耒阳市| 崇义县|